This approach could facilitate a quantitative study of variables such as lymphopenia, albumin, glucose control, sarcopenia, and weight loss in relation to clinic days, hospital days, documented infections, disease-free survival, and overall survival. The gene discussed is ALB; the disease is sarcopenia.